Diabetes mellitus and the impact on triglycerides
Article Sidebar
Main Article Content
Abstract
Atherosclerosis at the diabetic patient is based on lipoproteins in the form of small and dense particles with an increased capacity for subendothelial penetration and the production of atheroma plaque.
We conducted a retrospective study on a number of 217 patients with diabetes mellitus, with an average age of 61.53 years, being analyzed the importance of age, sex, type of diabetes, body mass index on triglyceride values.
Although no significant correlations were found between body mass index and triglyceride value, to improve glycemic control and lipid profile in obese patients with diabetes, weight loss is recommended
No statistical correlation was found between the value of the body mass index and glycated hemoglobin, respectively the value of triglycerides, there was observed a correlation, even if it was weak, between the value of glycated hemoglobin and triglycerides, underlining the importance of a permanent glycemic control in the prevention of atherosclerosis.
Article Details
References
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Romanian Journal of Cardiology
Vol. 30, No. 1, 2020
Chait A, Goldberg I. Treatment of dyslipidemia in diabetes: recent advances and remaining questions. Curr Diab Rep 2017;17:112
Ritsinger V, Hero C, Svensson AM, Saleh N, Lagerqvist B, EegOlofsson K, Norhammar A. Characteristics and prognosis in women and men with type 1 diabetes undergoing coronary angiography: a nationwide registry report. Diabetes Care 2018;41:876883.
Prospective Studies Collaboration and Asia Pacific Cohort Studies Collaboration. Sex-specific relevance of diabetes to occlusive vascular and other mortality: a collaborative meta-analysis of individual data from 980 793 adults from 68 prospective studies. Lancet Diabetes Endocrinol 2018;6:538546.
Ray KK, Seshasai SR, Wijesuriya S, Sivakumaran R, Nethercott S, Preiss D, Erqou S, Sattar N. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet 2009;373:17651772.
Control Group, Turnbull FM, Abraira C, Anderson RJ, Byington RP, Chalmers JP, Duckworth WC, Evans GW, Gerstein HC, Holman RR, Moritz TE, Neal BC, Ninomiya T, Patel AA, Paul SK, Travert F, Woodward M. Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia 2009;52:22882298.
Borg R, Kuenen JC, Carstensen B, Zheng H, Nathan DM, Heine RJ, Nerup J, Borch-Johnsen K, Witte DR; ADAG Study Group. HbA(1) (c) and mean blood glucose show stronger associations with cardiovascular disease risk factors than do postprandial glycaemia or glucose variability in persons with diabetes: the A1C-Derived Average Glucose (ADAG) study. Diabetologia 2011;54:6972.
Franz MJ, Boucher JL, Rutten-Ramos S, VanWormer JJ. Lifestyle weight-loss intervention outcomes in overweight and obese adults with type 2 diabetes: a systematic review and meta-analysis of randomized clinical trials. J Acad Nutr Diet 2015;115:14471463.
Tsutomu Hirano. Pathophysiology of Diabetic Dyslipidemia. J Atheroscler Thromb. 2018;25(9):771-782.
Schwartz CJ, Valente AJ, Sprague EA, Kelley JL, Cayatte AJ, Rozek MM: Pathogenesis of the atherosclerotic lesion. Implications for diabetes mellitus. Diabetes Care, 1992, 15:1156-1167.
American Diabetes association. Consensus Statement: Role of cardiovascular risk factors in prevention and treatment of macrovascular disease in diabetes. Diabetes Care, 1993, 16:72-78.
Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Interventional trial. Diabetes Care, 1993, 16:434-444.
Haffner SM, Lehto S, Rönnemaa T, PyöräläK Laakso, M Mortality. from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N. Engl. J. Med., 1998, 339:229-234.
Liang CP, Han S, Senokuchi T, Tall AR. The Macrophage at the Crossroads of Insulin Resistance and Atherosclerosis. Circ. Res., 200, 100:1546-1555.
Cubbon RM, Rajwani A, Wheatcroft SB. The impact of insulin resistance on endothelial function, progenitor cells and repair. Diab. Vasc. Di.s Res., 2007, 4:103-111.
Bornfeldt KE, Tabas I. Insulin Resistance, Hyperglycemia, and Atherosclerosis. Cell Metab., 2011, 14:575-585.
Laakso M: Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes, 1999, 48:937-942.
Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, Mitch W, Smith SC, Sowers JR: Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association [see comments]. Circulation, 1999, 100:1134-1146.
Aronson Doron and Elliot J Rayfield. How hyperglycemia promotes atherosclerosis: molecular mechanisms. Cardiovascular Diabetology, 2002, 1.1-10.